{
  "id": 15900098,
  "title": "AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.",
  "url": "https://urgent.news/2026/10/21/ai-can-design-antibodies-faster-than-anyone-can-check-them-for-immune",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-21T14:08:38.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/ai-can-design-antibodies-faster-than-anyone-can-check-them-for-immune-risk-that-gap-is-starting-to-close"
  },
  "original_language": "en",
  "account": null,
  "summary": "News Provided by Wall Street Investor on behalf of MindWalk Holdings Corp. AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) — Wall Street Investor News Commentary – Antibodies have become one of medicine’s most valuable drug classes, with 144 FDA-approved antibody drugs on the market as of August 2025 and global sales of more than $267 […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}